Intercytex Hair Multiplication Company Goes Out of Business

While no cure for hair loss yet exists, millions of balding men and women worldwide hope that hair multiplication (HM) will end baldness once and for all. By cloning derma papilla cells and injecting them into hairless scalp tissue, hair multiplication/cloning may eventually provide balding men and women with an unlimited supply of their own natural hair.

Intercytex and Aderans Research Institute are two major contenders in developing hair cloning amongst other treatments. However recently, Intercytex announced that they’re closing the doors after several long hard years of working to develop this hair loss treatment.

Patrick Hennessey, publisher of the Hair Transplant Network visited Intercytex’s hair multiplication operation in Manchester, England when he visited the Farjo Clinic back in May of 2007. While they appeared to have good management and promising preliminary results, their subsequent Phase II testing on humans failed to produce cosmetically significant hair regrowth.

Given the inconsistencies in hair growth observed in clinical studies, it would appear that discovering the potential of hair multiplication is still in its infancy stages. It’s suggested that the key to success may lie in growing stem cells in vitro to a hair follicle stage and then transplanting the hair follicles using today’s state of the art surgical hair restoration techniques.

To learn more about Intercytex and who may be taking over their research, visit “Intercytex discontinues its hair multiplication development operations“. You can also discuss this topic on our hair restoration forum.

Bill Seemiller
Managing Publisher
Follow our community on Twitter
Watch hair transplant videos  on YouTube

Technorati Tags: hair loss, balding, baldness, derma papilla cells, hair multiplication, Intercytex, Aderans Research Institute, hair cloning, hair loss treatment, hair regrowth, hair growth, hair restoration, Bill Seemiller